Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004063145 | SCV002750990 | uncertain significance | not specified | 2023-06-24 | criteria provided, single submitter | clinical testing | The p.K374E variant (also known as c.1120A>G), located in coding exon 7 of the IDH1 gene, results from an A to G substitution at nucleotide position 1120. The lysine at codon 374 is replaced by glutamic acid, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |